Psychologists in Warwick, NY Accepting Medicare
6 Psychologists found. Showing 1 - 6
 Dr. Karen Elizabeth Graves-scheffold, PSY.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 87 Onderdonk Rd, Warwick, NY 10990 Phone: 845-709-3439 |
 Dr. Joseph Roman, PH.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 210 Ronald Reagan Blvd, Warwick, NY 10990 Phone: 845-986-7171 Fax: 845-987-1372 |
Dr. Patti Knoblauch, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 35 Main St, Suite 2, Warwick, NY 10990 Phone: 845-988-0321 |
Dr. Karen Judith Berry, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 14 Union Corners Rd, Warwick, NY 10990 Phone: 845-987-9919 |
Dr. Sondra M Tuckfelt, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 56 Sleepy Valley Rd, Warwick, NY 10990 Phone: 845-986-7666 Fax: 845-986-7688 |
Dr. Deborah Bernstein, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 28 Railroad Ave, 4c-2, Warwick, NY 10990 Phone: 845-986-6684 |
News Archive
"Hotline" report on finasteride for prevention of prostate cancer
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
Johns Hopkins researchers find ways to curb common and deadly hospital-acquired infections
For some hospital patients, going on a ventilator is often the difference between life and death. About 800,000 hospital patients undergo mechanical ventilation each year in the United States due to a variety of illnesses or conditions, such as a brain injury, stroke or pneumonia.
Combination therapy effective for patients with cholangiocarcinoma marked by BRAF mutations
In a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, the combination of dabrafenib, a BRAF inhibitor, and trametinib, a MEK inhibitor, achieved a 51% overall response rate (ORR) in patients with cholangiocarcinoma marked by the BRAF V600E mutation.
Rosin soap as a potential SARS-CoV-2 disinfectant
In a research paper recently uploaded to the preprint server bioRxiv* by Bell et al. (July 19th, 2021), the potential of rosin soap as a virucide is investigated, finding a ten-thousand-fold drop in infectivity against enveloped viruses such as influenza and SARS-CoV-2 in particular.
Measuring the severity of COVID-19 using a model-based analysis
Researchers have modeled the progression and severity of COVID-19. Their study titled "Estimates of the severity of coronavirus disease 2019: a model-based analysis" was published in the latest issue of The Lancet Infectious Diseases.
› Verified 8 days ago
Clinical Social Workers
Counselors
Pharmacists
Occupational Therapists
Dentists
Psychologists